Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2013-10-31 01:30A WuXi PharmaTech CMO Facility Attains US GMP Certification and more...
2013-10-30 01:303SBio Acquires Rights to Novel Biologic Drug from SIMM
2013-10-29 01:30China Scientists Report Bird Flu Vaccine is Ready for Human Tests and more...
2013-10-27 01:30Week in Review: Fosun Pharma Strikes $531 Million Deal for Two Pre-Clinical Drugs
2013-10-26 01:30Fosun Sells China Rights for Diabetes Drug to Salubris and more...
2013-10-25 01:30Adimmune of Taiwan Readies Flu Vaccine for China
2013-10-24 01:30GSK Reports 61% Drop in China Revenues for Q3 and more...
2013-10-23 01:30China's Pharma Market to Reach $310 Billion in Revenues by 2020
2013-10-22 01:30Fosun Sells ex-China Rights for Two Drug Candidates in $531 Million Deal and more...
2013-10-20 01:30Week in Review: Eddingpharm In-licenses China Rights to Bone Drug for $2.7 Million Upfront
2013-10-19 01:30Eddingpharm Pays $2.7 Million Upfront for China Rights to Bone Drug
2013-10-18 01:30WuXi PharmaTech's Shanghai Lab Certified for Genomic Screening
2013-10-17 01:30Dance Biopharm Forms China Inhaled Insulin JV with Harmony Asset and more...
2013-10-16 01:30Miraculins and Cachet Sign LOI for China Rights to Diabetes Test
2013-10-15 01:30CardioKinetix Implants Heart Failure Device in China Patients
2013-10-13 01:30Week in Review: Hutchison MediPharma Partners Cancer Drug with Lilly
2013-10-12 01:30Chipscreen Out-licenses Taiwanese Rights for Cancer Drug to GNT Biotech and more...
2013-10-11 01:30Hutchison MediPharma Out-licenses Cancer Drug to Lilly for $86.5 Million and more...
2013-10-10 01:30ASLAN Pharma Raises $22 Million in B Round and more...
2013-10-09 01:30Police Arrest Alleged Bribery Agent in GSK China Scandal
2013-10-08 01:30Eddingpharm Gains China Rights to Cancer Drug from Immutep
2013-10-06 01:30Week in Review: Tasly Buys Stake in TCM Maker for $25 Million
2013-10-05 01:30Tasly Pays $25 Million for Stake in New Century Pharma
2013-10-04 01:30Hefei Life Science to Develop Micell's Stent in China
2013-10-03 01:30Lee's Pharma Completes Successful China Test of Anti-Depression Drug
2013-10-02 01:30Sanofi CEO Remains Positive on China and Other Emerging Markets
2013-10-01 01:30Parexel Forms Company Dedicated to China-Specific Approvals

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC